跳至主要内容
临床试验/CTRI/2021/08/035409
CTRI/2021/08/035409已完成1 期

Bubble Continuous Positive Airway Pressure Oxygen Therapy (Biodesign Innovation Labs’s RESPAP KIT )in Children under Five Years of Age with Pneumonia in Pediatric Intensive Care Unit (PICU)-A Pilot study

Biodesign Innovation Labss RESPAP KIT1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年1月8日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
The need for invasive ventilation (primary outcomes) 


研究概览

简要总结

This Prospective Observational Study study will be performed at St John’s medical college hospital, an urban tertiary referral hospital with 12-bedded PICU. The children from 5 months of age to 58 months of age meeting the inclusion criteria will be enrolled in the PICU. Children with mild to moderate respiratory distress score will be started on B-CPAP. The severity of respiratory distress will be determined using following variables, (respiratory rate, air entry, retractions, grunt, saturation in room air and level of consciousness). These variables will be recorded and graded according to modified Wood-Downes score. The highest scores from each variable were summed to attain the total severity score and graded as :1- 3, mild; 4-7, moderate; 8-12, severe. (19)

Aims and Objective(s) of the Study

This study is   planned to look at its effectiveness of B-CPAP in reducing the need for invasive ventilation and its safety as a form of respiratory support in children with pneumonia.

   Primary objective:

1)To determine  the efficacy and safety of Biodesign Innovation Labs’ Respap kit , a B-CPAP based oxygen therapy for children under 5 years with mild to  moderate respiratory distress due to  Pneumonia

 Secondary Objective:

  1. To assess the complications during use of B-CPAP and perception of ‘ease of use’ by nursing staff â€¨

研究设计

研究类型
Interventional

入排标准

年龄范围
5.00 Month(s) 至 60.00 Month(s)(—)
性别
All

入选标准

  • Children aged 5-59 months with diagnosis of pneumonia with mild to moderate respiratory distress.

排除标准

  • Those patients who required immediate intubation (<1hour), 2) low level of consciousness (GCS<10) 3)less than 24 hours of stay in PICU, 4) absent cough/ gag reflex, 5) hemodynamic instability 6)recent facial, upper airway or upper gastrointestinal tract surgery, 7)undrained pneumothorax 8)Hypercapnia (PCO2 > 60 mm of Hg),.

结局指标

主要结局

The need for invasive ventilation (primary outcomes) 


时间窗: 1st time point:6 hours | 2nd time point:24 hrs

2.Complications during use and perception of ‘ease of use’ by nursing staff (secondary outcomes)

时间窗: 1st time point:6 hours | 2nd time point:24 hrs

次要结局

  • Length of hospital stay ,duration of respiratory support(28 days)

研究者

发起方
Biodesign Innovation Labss RESPAP KIT
申办方类型
Other [Biodesign Innovation Labs’s RESPAP KIT]

研究点 (1)

Loading locations...

相似试验